Şunu aradınız:: radjuattivita (Maltaca - İngilizce)

igbed ammont ta ’ radjuattivita ’ sufficjenti.
leukoscan [99mtc] can be used after ten minutes and should be used within four hours after preparation.

trid tieħu prekawzjoni waħda minħabba r- radjuattivita:
there is one simple precaution because of the radioactivity:

dan ikun fih ammont ta’ radjuattivita’ bejn 740- 1110mbq
it will contain the radioactive technetium isotope in an amount called 740-1110 mbq.

radjuattivita` totali fiż-żewġ biċċiet ta' l-istrixxa itlc-sg mam
total radioactivity in both pieces of itlc-sg mam strip

dan l-iskan juri eżatt kif ir-radjuattivita` tkun mifruxa fil-ġisem.
this scan will show exactly the distribution of the radioactivity within the body.

dan jaghmlu billi juza scanner specjali li turi zoni ta ’ radjuattivita ’ biex jara fejn hemm l- infezzjoni.
the doctor does this by using a special imaging camera that reveals areas of radioactivity to see where the infections are located.

il - maġġoranza tar- radjuattivita` li toħroġ ma 'l- urina hija fil- forma oriġinali.
the majority of the radioactivity excreted in urine is in parent form.

b’ din it- tip ta ’ radjuattivita, ma hemmx effett dirett tar- radjazzjoni barra mill- ġisem.
with this type of radioactivity, there is no direct effect of radiation outside the body.

il- metodu primarju ta ’ l- eliminazzjoni tar- radjuattivita` kien permezz ta 'l- urina.
the primary route of elimination of radioactivity was the urine.

fi 2 minn 4 pazjenti b’metastasi fil-pulmun, ir-radjuattivita kienet assoċjata ma’ metastasi fil-pulmun.
in 2 of 4 patients with lung metastases, radioactivity was associated with lung metastases.

minn 1 sa 18% tad-doża tar-radjuattivita` li kienet injettata dehret fl-urina 4 sigħat wara l-injezzjoni.
one to 18% of the injected dose of radioactivity appeared in the urine at 4 hours after injection.

l-aktar metabolit ta’ tipranavir li nstab fl-ippurgar kien il-hydroxyl u ta riżultat ta’ 4.9% tar-radjuattivita ta’ l-ippurgar (3.2% tad-doża).
the most abundant faecal metabolite, at 4.9% of faecal radioactivity (3.2% of dose), was a hydroxyl metabolite of tipranavir.